Top in hem/onc: Financial management during a divorce, timing of chemotherapy

Proper planning is essential for protecting assets in the event of divorce, according to attorney David B. Mandell, JD, MBA. His financial guide concerning divorce was the top story in hematology/oncology last week.

Another top story revealed longer overall survival in patients with newly diagnosed glioblastoma who received temozolomide in the morning vs. the evening.

Read these and more top stories in hematology/oncology below:

How to shield your assets in a divorce

Of all the risks to doctors, the most common threat to long-term financial security may be divorce. Yet, what can physicians do to protect from this risk? Read more.

Preliminary data show survival benefit of morning temozolomide for glioblastoma

Morning administration of temozolomide appeared to be associated with longer overall survival compared with evening administration among patients with newly diagnosed glioblastoma, according to study results published in Neuro-Oncology Advances. Read more.

Tailored interventions may mitigate sleep disturbances among women with breast cancer

Tailored interventions that address pain, anxiety, fatigue or perceived stress may benefit women with breast cancer who experience sleep disturbance, according to study results presented at the virtual Oncology Nursing Society Congress. Read more.

Motixafortide regimen shows ‘impressive’ activity in transplant setting for myeloma

The addition of motixafortide to standard treatment improved hematopoietic stem cell target mobilization for autologous bone marrow transplantation among patients with multiple myeloma, according to the agent’s manufacturer. Read more.

Increased BMI associated with risk for second cancer among breast cancer survivors

Higher BMI appeared to be associated with a statistically significant increased risk for second cancers among women diagnosed with invasive breast cancer, according to a study published in Journal of the National Cancer Institute. Read more.